Litcius/Paper detail

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells

Kenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama, Hirohisa Ogawa, Hirokazu Ogino, Atsuro Saijo, Hiroyuki Kozai, Hiroto Yoneda, Makoto Tobiume, Masatoshi Kishuku, Keisuke Ishizawa, Yasuhiko Nishioka

2020Lung Cancer19 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePemetrexedMesotheliomaCancer researchAntibodyCisplatinChemotherapyLung cancerMesothelinImmunologyPathologyInternal medicineImmune cells in cancerOccupational and environmental lung diseasesCancer Immunotherapy and Biomarkers
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells | Litcius